Generic placeholder image

Current Topics in Medicinal Chemistry


ISSN (Print): 1568-0266
ISSN (Online): 1873-4294

Small Molecule p38 MAP Kinase Inhibitors for the Treatment of Inflammatory Diseases: Novel Structures and Developments During 2006- 2008

Author(s): Liping H. Pettus and Ryan P. Wurz

Volume 8, Issue 16, 2008

Page: [1452 - 1467] Pages: 16

DOI: 10.2174/156802608786264245

Price: $65


The p38 mitogen-activated protein (MAP) kinase plays a central role in inflammation. It has been the subject of extensive efforts in both basic research and drug discovery for the treatment of inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease, and psoriasis, where aberrant cytokine signaling is the driver of the disease. This article reviews the patent and journal publication activities during 2006-2008 describing novel small molecule p38α inhibitors.

Keywords: mitogen-activated protein (MAP), p38, Kinase Inhibitors, inflammation, rheumatoid arthritis, cytokine, bowel disease

Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy